Page last updated: 2024-08-22

erbium and ER-Negative PR-Negative HER2-Negative Breast Cancer

erbium has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, M; Ming, L; Shi, J; Song, L; Wang, R; Xu, J; Zhang, Y	1

Other Studies

1 other study(ies) available for erbium and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Smart Manganese Dioxide-Based Lanthanide Nanoprobes for Triple-Negative Breast Cancer Precise Gene Synergistic Chemodynamic Therapy. ACS applied materials & interfaces, 2021, Aug-04, Volume: 13, Issue:30 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Down-Regulation; Drug Carriers; Drug Therapy; Erbium; Genetic Therapy; Glutathione; Humans; Manganese Compounds; Metal Nanoparticles; Mice, Nude; Oxides; RNA, Small Interfering; S100 Calcium-Binding Protein A4; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2021

Article

Year

Smart Manganese Dioxide-Based Lanthanide Nanoprobes for Triple-Negative Breast Cancer Precise Gene Synergistic Chemodynamic Therapy.

ACS applied materials & interfaces, 2021, Aug-04, Volume: 13, Issue:30

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Down-Regulation; Drug Carriers; Drug Therapy; Erbium; Genetic Therapy; Glutathione; Humans; Manganese Compounds; Metal Nanoparticles; Mice, Nude; Oxides; RNA, Small Interfering; S100 Calcium-Binding Protein A4; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2021